Hangzhou Alltest Biotech Co., Ltd. (688606.SS)

CNY 66.01

(-0.14%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 4.11 Billion 4.69 Billion 4 Billion 1.15 Billion 332.5 Million 254.56 Million
Total Current Assets 3.16 Billion 4.18 Billion 3.66 Billion 1.02 Billion 239.47 Million 171.23 Million
Cash And Short Term Investments 2.78 Billion 3.81 Billion 2.95 Billion 700.63 Million 125.25 Million 11.94 Million
Cash and Cash Equivalents 1.31 Billion 1.98 Billion 2.17 Billion 285.63 Million 63.25 Million 11.94 Million
Short Term Investments 1.47 Billion 1.83 Billion 780.2 Million 415 Million 62 Million 35 Million
Net Receivables 122.1 Million 171.08 Million 306.41 Million 182.98 Million 55.41 Million 71.05 Million
Inventory 188.59 Million 193.65 Million 383.84 Million 123.72 Million 54.5 Million 42.55 Million
Other Current Assets 61.83 Million 9.71 Million 18.4 Million 17.82 Million 4.3 Million 45.67 Million
Total Non-Current Assets 954.6 Million 510.54 Million 340.16 Million 125.93 Million 93.02 Million 83.32 Million
Net PPE 759.8 Million 317.14 Million 223.62 Million 66.81 Million 51.87 Million 45.25 Million
Good Will And Intangible Assets 110.43 Million 93.02 Million 28.11 Million 28.78 Million 15.87 Million 16.26 Million
Good Will - - - - - -
Intangible Assets 110.43 Million 93.02 Million 28.11 Million 28.78 Million 15.87 Million 16.26 Million
Long-Term Investments -1.44 Billion -1.82 Billion -725.88 Million 2.15 Million 2.25 Million 2.55 Million
Tax Assets 30.17 Million 51.33 Million 3.82 Million 4.06 Million 1.89 Million 1.73 Million
Other Non Current Assets 1.5 Billion 1.86 Billion 810.48 Million 24.1 Million 21.12 Million 17.52 Million
Other Assets - - 1.00 - 1.00 1.00
Total Liabilities 284.49 Million 528.8 Million 734.7 Million 178.44 Million 39.3 Million 39.46 Million
Total Current Liabilities 274.16 Million 510.75 Million 714.2 Million 178.44 Million 39.3 Million 39.46 Million
Account Payables 77.6 Million 171.17 Million 360.65 Million 62 Million 16.6 Million 21.3 Million
Tax Payables 82.62 Million 108.05 Million 72.33 Million 56.93 Million 1.42 Million 3.49 Million
Short Term Debt 16.25 Million 8.32 Million 20.06 Million 2.22 Million -8.5 Million -6.28 Million
Deferred Revenue 180.13 Million - 332.89 Million 33.38 Million 8.5 Million 6.28 Million
Other Current Liabilities 160.05 Thousand 331.25 Million 598.1 Thousand 80.83 Million 22.69 Million 18.16 Million
Total Non Current Liabilities 10.33 Million 18.04 Million 20.5 Million 2.2 Million - -
Long-Term Debt 7.65 Million 13.44 Million 17.3 Million 2.2 Million - -
Deferred Revenue Non Current 2.67 Million -4.6 Million -3.19 Million - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.00 4.6 Million 3.19 Million - - -
Other Liabilities -0.00 1.00 1.00 -2.2 Million - -
Total Equity 3.83 Billion 4.17 Billion 3.27 Billion 972.66 Million 293.2 Million 215.09 Million
Stock Holders Equity 3.82 Billion 4.16 Billion 3.27 Billion 972.66 Million 293.2 Million 215.09 Million
Common Stock 79.28 Million 53.9 Million 53.9 Million 40.4 Million 40.4 Million 40.4 Million
Retained Earnings 1.84 Billion 2.2 Billion 1.32 Billion 746.42 Million 135.15 Million 64.67 Million
Accumulated other comprehensive income 3.74 Billion 287.92 Million 160.95 Million 82.99 Million 14.84 Million 7.21 Million
Common Stock Equity 3.82 Billion 4.16 Billion 3.27 Billion 972.66 Million 293.2 Million 215.09 Million
Capital Lease Obligation 7.65 Million 13.44 Million 17.3 Million 2.2 Million - -
Total Investments 22.94 Million 12.19 Million 54.32 Million 415 Million 62 Million 2.55 Million
Total Debt 23.91 Million 21.76 Million 37.36 Million 4.42 Million - -
Net Debt -1.29 Billion -1.96 Billion -2.14 Billion -281.21 Million -63.25 Million -11.94 Million

Balance Sheet Charts